Government to help Pfizer expand production capacity

Pfizer CEO Albert Bourla on Covid-19 vaccine manufacturing outlook

Earlier, the company announced that it asked to ease some restrictions on supplies.

U.S. authorities are working with pharmaceutical company Pfizer to help it maximize production capacity for the COVID-19 vaccine due to potential manufacturing challenges, Health and Welfare Secretary Alex Azar told reporters..

The company itself has not yet commented, but its CEO Albert Burla told CNBC earlier this week that the company is asking the US government to use the Defense Manufacturing Act to ease some “critical supply constraints,” especially on certain components..Government to help Pfizer expand production capacity He did not provide additional details.

Officials did not say exactly what production problems the company faced. They said they were very familiar with the manufacturing materials and equipment needed to make vaccines, based on experience with other drug manufacturers..

“Recently, they finally briefed us on the various problems that may arise in manufacturing, and we are putting in place whatever mechanisms are needed to help them produce products for the American people,” Azar said..

Pfizer BioNTech partner Ugur Shahin told Reuters last week that the previously announced production of 100 million doses in 2020 has been cut in half, in part due to raw material supply problems..Government to help Pfizer expand production capacity According to him, the problems were subsequently settled and production began on a large scale..

The US government is actively negotiating with Pfizer to secure 100 million additional doses, Chief Advisor to Operation Supersonic, Dr. Moncef Sloughi, told reporters. Previously signed an option contract with Pfizer to purchase up to 500 million additional doses at an unspecified price.

The government said Wednesday that the United States has already agreed to supply 300 million doses of Pfizer / BioNTech and Moderna vaccines in the coming months. In total, it is planned to purchase 900 million doses of vaccines from different manufacturers.

Moderna vaccine expected to receive regulatory approval as early as Friday.

Similar articles